Residues of macrolide antibiotics in eggs following medication of laying hens

1. The elimination kinetics of four macrolide antibiotics (tylosin, erythromycin, spiramycin and josamycin) in eggs were determined separately for albumen and yolk after oral administration through either drinking water or diet or after intramuscular injection. 2. Residues were assayed by a plate diffusion technique in cylinders with Micrococcus luteus as the test-organism. 3. Drug excretion was usually over a longer time in the yolk. Spiramycin was the most highly excreted in the egg whereas seven to eight times less tylosin and erythromycin was transferred. The conditions for the use of macrolide antibiotics in laying hens are discussed.     

Residues of gentamicin in eggs following medication of laying hens

1. Gentamicin was injected subcutaneously and intramuscularly into 5 groups of 10 laying hens and its concentration was determined in albumen, yolk and whole egg. 2. Groups 1 and 3 were intramuscularly injected with doses of 10 and 25 mg/kg while groups 2, 4 and 5 were subcutaneously injected with doses of 10, 25 and 50 mg/kg, respectively. 3. The final gentamicin concentration in albumen was measured on d 3 for groups 1 and 2; on d 4 for groups 3 and 4, and on d 5 for group 5. Concentrations in yolk and whole egg were measured on d 7, 10 and 12. 4. Gentamicin recovery was as follows: 2% in groups 1 and 2, 2.5% in groups 3 and 4, and 3% in group 5. 5. Most of the residue (approximately 90%) was recovered from the yolk.     

Residues of drugs in eggs after medication of laying hens for eight days.

Drug residues in blood plasma, egg-white and -yolk have been measured for 3 weeks after 8 days of continuous treatment with sulphanilamide, sulphadimidine, sulphaquinoxaline and pyrimethamine. The results are discussed with reference to physiological data concerning eggwhite and -yolk formation. From this, it is concluded that a withdrawal period of at least 10 days after the disappearance of drug in blood plasma is necessary to avoid residues of drugs in eggs from treated hens.     

Residues of dimetridazole in eggs after treatment of laying hens

Laying hens were dosed orally with dimetridazole (DMZ) (50 and 250 mg/kg) for 3 days or intramuscularly (50 mg/kg), also for 3 days, and the residues were determined by liquid chromatography in albumen and yolk. The sensitivity of the whole procedure was 2 ng/g. The drug was excreted preferentially into the yolk (about 57% of the total) and the elimination period lasted for 4–6 days after treatment.Abbreviations AUC area under the plasma concentration-time curve - depletion time the time needed for the DMZ concentration to fall below 0.01 g/g - elimination rate constant - Cl clearance - DMZ demetridazole     

Depletion of colistin in eggs following medication of laying hens

The depletion of colistin in eggs was determined separately for the albumen, the yolk and the whole egg after oral and intramuscular administrations of colistin sulphate. Residues were assayed by an agar plate diffusion method with Bordetella bronchoseptica ATCC 4617 as test organism. Colistin residues were not detected after drug administration by the oral route, but could be detected in the yolk until eight days after intramuscular injection. The total amount excreted represented 0.9% of the dose applied.     

Residues of sulphadimidine and its metabolites in eggs following oral sulphadimidine medication of hens

Summary

The depletion of sulphadimidine(SDM) and its N₄‐acetyl and hydroxy metabolites was studied in eggs laid by hens after administration of either a single or multiple oral dosages of 100 mg SDM/kg. During medication and until I day after the last dose, the SDM and its metabolite concentrations in the egg white exceeded those in the egg yolk and reflected the plasma levels. In the period starting 2 days after the (last) dosage, the SDM concentration in the yolk became higher than in the egg white, and the drug depletion curves ran parallel. The mean maximum amount of SDM found in the whole egg was 1500 μg after a single and 1280 pg after multiple dosage. In eggs, traces of the N₄‐acetyl and 6‐methylhydroxy metabolites could be detected (mainly in the egg white), and their concentrations were approximately 40 times lower than those of the parent drug. A highly significant correlation (P< 0.005) was found between the development stage of the oöcyte at the time of (last) medication and the amount of SDM found in the egg that developed from it. A period of 7 or 8 days after the (last) dosage of 100 mg SDM/kg/day is required to obtain SDM levels below 0.1 μg/g egg.     

Residues of sulphadimidine and its metabolites in eggs following oral sulphadimidine medication of hens

The depletion of sulphadimidine (SDM) and its N4-acetyl and hydroxy metabolites was studied in eggs laid by hens after administration of either a single or multiple oral dosages of 100 mg SDM/kg. During medication and until 1 day after the last dose, the SDM and its metabolite concentrations in the egg white exceeded those in the egg yolk and reflected the plasma levels. In the period starting 2 days after the (last) dosage, the SDM concentration in the yolk became higher than in the egg white, and the drug depletion curves ran parallel. The mean maximum amount of SDM found in the whole egg was 1500 micrograms after a single and 1280 micrograms after multiple dosage. In eggs, traces of the N4-acetyl and 6-methylhydroxy metabolites could be detected (mainly in the egg white), and their concentrations were approximately 40 times lower than those of the parent drug. A highly significant correlation (P less than 0.005) was found between the development stage of the oocyte at the time of (last) medication and the amount of SDM found in the egg that developed from it. A period of 7 or 8 days after the (last) dosage of 100 mg SDM/kg/day is required to obtain SDM levels below 0.1 micrograms/g egg.     

Elimination of oxolinic acid in eggs after oral treatment of laying hens

1. Oxolinic acid is often used in poultry as a therapeutic agent. The aim of this study was to determine both its elimination into eggs, following oral dosing through the drinking water (12 mg/kg/d) or diet (13 mg/kg/d) for 5 d and its plasma concentrations. 2. Samples (albumen, yolk, plasma) were analysed by high performance liquid chromatography (HPLC) with fluorimetric detection. The limits of quantification were 10 ng/g in plasma and 5 ng/g in albumen and yolk. Residues were much higher in albumen than in plasma, whereas they were lower in yolk. 3. 95% of the overall oxolinic acid detected in eggs was concentrated in the albumen. 4. Detectable residues persisted for 9 d and 7 d, respectively, in albumen and yolk after the treatment was discontinued.     

Distribution of 15N-chlorocholine chloride in eggs of laying hens

The distribution of Chlorocholine chloride (CCC) in the eggs of laying hens was studied using 15N-CCC. Twelve layers (37 weeks old) were divided into four groups and used in this study consisting of three feeding phases. In phase one (7 days), all the hens received a CCC-free diet [165 g CP/kg dry matter (DM); 11.58 MJ ME/kg DM]. In phase two (11 days), four levels of 15N-CCC: 0, 5, 50 and 250 ppm were added to the respective diets, while in phase three (7 days), CCC-free feed was again offered. Egg samples were taken and the 15N content of egg yolk and albumin were determined. At the end of phase two, there was a significant (p < 0.05) increase in 15N content in egg yolk from hens fed the 50 and 250 ppm CCC diets and in albumin from hens fed the 250 ppm CCC diet. The estimated 15N-CCC residue was 1.71, 6.64, 28.80 ppm in egg yolk and 1.58, 1.08 and 4.50 ppm in albumin from hens fed 5, 50 and 250 ppm CCC, respectively. The CCC residue, from quantitative analysis ranged from 0.21 to 0.93 and 0.93 to 2.43 ppm in yolk of hens fed 50 and 250 ppm CCC, respectively, whereas a range of 0.40-1.46 ppm, was found in the albumin of hens fed 250 ppm. The difference in measured CCC in yolk and albumin and that estimated from 15N-CCC could have been due to breakdown products of 15N-CCC. Seven days after withdrawal of 15N-CCC, the estimated 15N-CCC residue in egg yolk decreased to 0.43, 2.45 and 15.59 ppm, on 5, 50 and 250 ppm CCC dietary treatments, respectively, and to 2.46 ppm in albumin from hens fed 250 ppm CCC. The higher increase in 15N content could have been due to a higher incorporation of 15N-CCC into yolk than albumin during the process of rapid yolk deposition. This experiment showed that consumed CCC is distributed both into yolk and albumin in a dose dependent manner and that CCC is metabolized in laying hens. However, the level of CCC in the diet which could lead to accumulation of detectable CCC levels in eggs as observed in this study, is much higher than the established maximum residual limits in grains.     

槲皮素对蛋鸡产蛋后期蛋品质的影响

选用体重和产蛋率相近的39周龄海赛白壳蛋鸡240只,随机分4组,每组6个重复,每重复10只鸡,分别在玉米-豆粕饲粮基础上添加0%、0.02%、0.04%、0.06%槲皮素饲喂蛋鸡,研究槲皮素对蛋品质的影响。结果表明,与对照组相比,不同添加水平槲皮素对蛋形指数、蛋壳强度、蛋清中蛋白质含量、蛋黄中粗脂肪含量及血清中胆固醇和血磷含量均无显著影响(P>0.05);0.04%和0.06%槲皮素组蛋壳厚度(P<0.01)、哈氏单位(P<0.01)、蛋黄总磷脂(P<0.01)及血清中总蛋白(P<0.05)和血钙(P<0.05)含量均显著提高;不同添加水平槲皮素对蛋黄颜色影响均极显著(P<0.01);0.04%槲皮素组蛋黄中蛋白质含量显著提高(P<0.05);0.06%槲皮素组蛋黄中胆固醇含量极显著降低(P<0.01),但与其他两个添加水平组无显著差异(P>0.05);0.06%槲皮素组血清中尿素氮含量显著降低(P<0.05);0.04%槲皮素组血清中尿酸含量显著降低(P<0.05)。综上所述,槲皮素可有效改善蛋鸡产蛋后期的蛋品质,其最适添加水平为0.04%。     

Study of enrofloxacin and flumequine residues depletion in eggs of laying hens after oral administration

Two groups of laying hens (each n=12) were administered 10 mg/kg enrofloxacin (ENRO) (group A) or 26.6 mg/kg flumequine (FLU) (group B) by gastric catheter daily for five consecutive days. A third group (n=6) was untreated controls. Eggs were collected from day one of treatment and up to 30 days after withdrawal of the drug. Egg white and yolk from each egg were separated, and ENRO, its metabolite ciprofloxacin (CIP) and FLU residues were analysed by a high-performance liquid chromatography method with fluorescence detection. The sum of ENRO and CIP was detectable in egg white on the first day of treatment in high-level concentrations (2007.7 μg/kg) and remained steady during administration. In egg yolk, residues were detectable at day one in lower concentrations (324.4 μg/kg), increasing to the end of treatment. After treatment, these residues decreased and were detectable up to day 8 in egg white, and day 10 in yolk. FLU residues during drug administration in white were detectable in high concentrations from day one to five (6788.4-6525.9 μg/kg), and in yolk, concentrations were lower during administration (629.6-853.9 μg/kg). After drug withdrawal, FLU residues remained longer in egg white (30 days) than in yolk (26 days). For both drugs, differences of concentrations between matrices were significant.     

Lead concentrations in the blood and eggs of backyard laying hens

AIMS: To investigate the prevalence of lead exposure in hens and eggs from backyard poultry in a sample of Auckland households, the relationship between concentrations of lead in the blood of the hens and in the shells and yolks of eggs from the same household, and to examine associations with measures of hen health, environment and husbandry factors.

METHODS: Thirty households participated in the study from August to November 2016, each providing one adult hen for sampling, an egg from the household if available, and completing a questionnaire on hen husbandry. Concentrations of lead in blood were determined using a portable lead analyser. Eggs were analysed for concentrations of lead in the yolk and shell using inductively coupled plasma mass spectrometry after biological digestion with a mixture of nitric and hydrochloric acid.

RESULTS: Twenty three of 30 hens (77%) showed evidence of lead exposure, with median concentrations of lead in blood of 0.77 (min?<0.16, max 8.02) μmol/L. All eggs showed evidence of lead exposure, with concentrations of lead in the yolk ranging from 0.003–1.07?mg/kg, and concentrations of lead in the eggshell ranging from <0.1–0.82?mg/kg. A positive correlation existed between concentrations of lead in the blood of a hen and concentrations of lead in egg yolk from the same hen (R²=0.97), and both the yolk (R²=0.58) and shell (R²=0.30) of an egg from her flock. No association was found between concentrations of lead in blood and hen health indices measured in this study. Concentrations of lead in blood were higher in hens from properties with homes built before 1941 than between 1941–1960 (p=0.03), and in hens from properties with weatherboard homes than brick homes (p=0.049).

CONCLUSIONS AND CLINICAL RELEVANCE: There was a high prevalence of lead exposure in this sample of Auckland backyard chickens, with the majority of hens being sub-clinically affected. Associations were found between concentrations of lead in the blood of the hens, and properties with homes built before 1941 and clad in weatherboard. Concentrations of lead in over half the egg yolks sampled were at levels sufficient to warrant human health concern. The assessment of concentrations of lead in backyard poultry and eggs intended for human consumption is recommended to protect human and bird health.     

Pharmacokinetics of tapentadol in laying hens and its residues in eggs after multiple oral dose administration

1. The aim of the study was to evaluate the pharmacokinetics (PKs) of tapentadol (TAP), a novel opioid analgesic, in laying hens after intravenous (IV) and oral (PO) administration and to quantify the concentrations of TAP residues in eggs.

2. Twenty healthy laying hens were divided into three groups: A (n = 6), B (n = 6) and C (n = 8). The study was conducted in two phases. Groups A and B received TAP by IV and PO routes at the dose of 1 and 5 mg/kg, respectively.

3. No visible adverse effects were observed after administration of the drug. TAP plasma concentrations were detectable up to 4 h following administration. Following IV administration, TAP plasma concentrations were only higher than the minimal effective concentration (148 ng/ml) reported for humans for 1 h. After single PO administration, plasma concentrations of TAP would not conform to software algorithms and the PK parameters were not calculated. TAP concentration following multiple PO doses at 5 mg/kg for 5 d was found to be higher and more persistent (12 h vs. 7 h) in yolk compared with albumen.

4. This is the first PK study on the novel atypical opioid TAP in laying hens. Further studies are required to investigate the analgesic efficacy and actual effective plasma concentration of TAP in this species.     

Regulation of net intestinal calcium uptake in hens laying obligatory soft-shelled eggs

1. Individually caged laying hens had a loop of thread inserted into the shell gland. This resulted in the laying of soft shelled eggs. 2. A balance study was performed for a one week period before and after the operation. After the operation birds with threads consumed less calcium than before. Their requirements for calcium for eggshells decreased, resulting in increases in both calcium excreted and calcium retained. 3. Net calcium extraction in the digestive tract was measured in groups of birds with threads and intact controls, when shelling or not, by examining ratios of Ca to TiO2 in different gut segments. Observations were made during the period following premature oviposition in birds with threads, but within the normal shelling period of control birds. The period of study was at least two weeks after the operation. 4. Birds with threads absorbed less calcium than control birds up to the upper jejunum. 5. Control birds secreted calcium between the upper jejunum and colon, but birds with threads showed little change in absorption in this part of the digestive tract. 6. The increase in calcium absorption in intact birds was a response to the stimulus of shelling an egg or replacing calcium in medullary bone during a pause day, rather than of ovulation.     

无公害蛋鸡与鸡蛋生产技术要点

无公害蛋鸡与鸡蛋，是指产地环境、生产过程和最终产品符合国家无公害食品标准和规范，经专门机构认定，按照国家《无公害农产品管理办法》的规定，许可使用无公害农产品标识的产品。无公害蛋鸡与鸡蛋符合国家食品卫生标准，具有无污染、安全、优质及营养的特点。随着加入WTO和北京、上海等大中城市陆续实行农     

产蛋鸡群发病后的科学管理

产蛋鸡群的科学管理是最大发挥蛋鸡生产性能、提高效益的根本保证，也是提高鸡群防御机能、防治鸡病的关键措施。目前，产蛋鸡群发病后由于管理不当造成病愈后产蛋难以达到高峰或恢复以前水平的现象在大多数蛋鸡场普遍存在，严重影响了蛋鸡生产性能的发挥。因此，必须加强和重视产蛋鸡群发病后的科学管理。现将产蛋鸡群发病后的科学管理作一概述，以供养鸡同行参考。     

Plasma dispositions and concentrations of ivermectin in eggs following treatment of laying hens

AIMS: To determine the plasma disposition and concentrations of ivermectin (IVM) in eggs produced by laying hens following S/C, oral and I/V administration.

METHODS: Twenty-four laying hens, aged 37 weeks and weighing 1.73 (SD 0.12) kg were allocated to three groups of eight birds. The injectable formulation of IVM was administered either orally, S/C, or I/V, at a dose of 0.2?mg/kg liveweight, following dilution (1:5, v/v) with propylene glycol. Heparinised blood samples were collected at various times between 0.25 hours and 20 days after drug administration. Eggs produced by hens were also collected daily throughout the study period. Samples of plasma and homogenised egg were analysed using HPLC.

RESULTS: Maximum concentrations of IVM in plasma and mean residence time of IVM were lower after oral (10.2 (SD 7.2) ng/mL and 0.38 (SD 0.14) days, respectively) than after S/C (82.9 (SD 12.4) ng/mL and 1.05 (SD 0.24) days, respectively) administration (p<0.01). The time to maximum concentration and elimination half-life were shorter following oral (0.14 (SD 0.04) and 0.23 (SD 0.11) days, respectively) than S/C (0.25 (SD 0.00) and 1.45 (SD 0.45) days, respectively) administration (p<0.01). IVM was first detected in eggs 2 days after treatment in all groups and was detected until 8 days after oral and I/V administration, and until 15 days after S/C administration. Peak concentrations of IVM were 15.7, 23.3 and 1.9?µg/kg, observed 2, 5 and 4 days after I/V, S/C and oral administration, respectively.

CONCLUSIONS AND CLINICAL RELEVANCE: The low plasma bioavailability of IVM observed after oral administration in laying hens could result in lower efficacy or subtherapeutic plasma concentrations, which may promote the development of parasitic drug resistance. Due to high IVM residues in eggs compared to the maximum residue limits for other food-producing animal species, a withdrawal period should be necessary for eggs after IVM treatment in laying hens.     

Characteristics of Salmonella enteritidis contamination in eggs after oral,aerosol, and intravenous inoculation of laying hens

Experimental infection models are useful tools for understanding how Salmonella enteritidis is deposited in eggs and for testing potential strategies to control eggborne transmission of disease to humans. Oral inoculation of laying hens is presumed to provide the closest simulation of naturally occurring infections, but alternatives such as intravenous or aerosol inoculation have sometimes been recommended as options to induce higher incidences of egg contamination. The present study compared the frequency, level, and location of S. enteritidis deposition in egg contents after experimental inoculation by three different routes. In two replicate trials, specific-pathogen-free laying hens were infected with an S. enteritidis culture mixture prepared to optimize invasive behavior. Groups of hens received either an oral dose of 10(9) S. enteritidis, an aerosol dose of 10(9) S. enteritidis, or an intravenous dose of 10(5)-10(7) S. enteritidis. Oral inoculation led to the highest incidence of fecal shedding of S. enteritidis, whereas intravenous inoculation produced the highest specific antibody titers. Eggs laid during the first 21 days postinoculation were cultured to detect and enumerate S. enteritidis in the yolk and albumen. No significant differences were observed among the three inoculation routes in the frequencies of isolation of S. enteritidis from either yolk or albumen. For all three routes of administration, S. enteritidis was recovered more often from yolk (at frequencies ranging from 4% to 7%) than from albumen (0 to 2%). Over 73% of contaminated eggs harbored fewer than 1 colony-forming unit (CFU) of S. enteritidis per milliliter, and only 3% of such eggs contained more than 100 CFUs/ml. Significantly higher levels of S. enteritidis contaminants were associated with intravenous inoculation than with the other routes. No advantage of using aerosol or intravenous administration of S. enteritidis as an alternative to oral inoculation for inducing the production of contaminated eggs was evident in this study.     

高效液相色谱荧光检测法检测鸡蛋中甲砜霉素残留

建立了用高效液相色谱荧光检测法检测鸡蛋中甲砜霉素残留量的方法。样品经碱性乙酸乙酯提取,饱和正己烷脱脂,氮吹仪吹干浓缩后,以乙腈-磷酸二氢钠溶液（0.01mol/L,含0.005mol/L L十二烷基硫酸钠和0.1%三乙胺）（35∶65）为流动相,流速为1.0mL/min,荧光检测激发波长为224nm,发射波长为290nm。甲砜霉素在0.025～5.0mg/L质量浓度范围内,本方法线性关系良好,相关系数为0.999 7。当甲砜霉素添加水平为15～500μg/kg时,该方法平均回收率为86.35%～93.76%,相对标准偏差为4.21%～7.89%,日内相对标准偏差为4.84%～6.62%;日间相对标准偏差为8.92%～10.83%。甲砜霉素最低检测限为1.5μg/kg（S/N=3）,最低定量限5μg/kg（S/N=10）。所建立的方法简便、快速、灵敏度高,适用于鸡蛋中甲砜霉素残留的高灵敏度检测。